← 홈

Antibody

1,230개 · ADC 1032 · Antibody 4683 · CGT 2713 · 다음 갱신 D-6 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,230개
AntibodystaleRochePhase 2

trastuzumab (Herceptin, PLD, cyclophosphamide, trastuzumab, paclitaxel)

Breast Neoplasm · Breast Neoplasm

#BreastNeoplasm#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

PRECISION dosing Infliximab (PRECISION dosing Infliximab)

Inflammatory Bowel Disease · Inflammatory Bowel Disease

#InflammatoryBowelDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 3

PTC+Pertuzumab (PTC+Pertuzumab)

Breast Cancer; HER2 Positive · HER2

#HER2#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleSCRI Development Innovations, L…Phase 1

PTK787/ZK222584 and Bevacizumab (PTK787/ZK222584 and Bevacizumab)

Refractory Malignancy; Advanced Malignancies · FRα

#FR#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleJiangsu HengruiPhase 2

PVE+cTACE+Camrelizumab+Apatinib (PVE+cTACE+Camrelizumab+Apatinib)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

atezolizumab (Tecentriq, PXS-5505 and Atezolizumab and Bevacizumab)

Hepatocellular Carcinoma; Cancer of Liver · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleSamsung Medical CenterPhase 2

atezolizumab (Tecentriq, Pabociclib, Endocrine, Pabociclib, Endocrine(or ET + CDK4/6 inhibitors), Talazoparib, Atezolizumab, or ET + CDK4/6 inhibitors)

Premenopausal HR+/HER2- Metastatic Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleThe Netherlands Cancer InstitutePhase 2

atezolizumab (Tecentriq, Paclitaxel + Atezolizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleJapanese Foundation for Cancer …Phase 3

atezolizumab (Tecentriq, Paclitaxel + bevacizumab + atezolizumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJapanese Foundation for Cancer …Phase 3

Paclitaxel + bevacizumab therapy (Paclitaxel + bevacizumab therapy)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleFudan UniversityPhase 2

trastuzumab (Herceptin, Paclitaxel polymer micelles combined with trastuzumab, pertuzumab, and adrelumab)

Advanced HER2-positive Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleMerrimack PharmaceuticalsPhase 1

trastuzumab (Herceptin, Paclitaxel, Trastuzumab and MM-111)

HER-2 Gene Amplification · HER-2 Gene Amplification

#HER-2GeneAmplification#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJungsil RoPhase 2

trastuzumab (Herceptin, Paclitaxel/Gemcitabine/Trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSun Yat-sen UniversityPhase 2

trastuzumab (Herceptin, Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant)

Breast Cancer; Brain Metastases · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleAbbVie (prior sponsor, Abbott)Phase 3

Palivizumab (Palivizumab)

Respiratory Syncytial Virus Infection · Respiratory Syncytial Virus Infection

#RespiratorySyncytialVirusInfecti#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenApproved

Palmitoleic Acid + Infliximab (Palmitoleic Acid + Infliximab)

Crohn's Disease · Crohn's Disease

#CrohnsDisease#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleKyntra BioPhase 2

Pamrevlumab (Pamrevlumab)

Idiopathic Pulmonary Fibrosis · Idiopathic Pulmonary Fibrosis

#IdiopathicPulmonaryFibrosis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleChinese PLA General HospitalPhase 2

Pancreatic cancer: Tunlametinib + cetuximab β (Pancreatic cancer: Tunlametinib + cetuximab β)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleChinese PLA General HospitalPhase 2

Pancreatic cancer: Tunlametinib +Nimotuzumab (Pancreatic cancer: Tunlametinib +Nimotuzumab)

Treatment for Advanced Colorectal Cancer; Treatment for Advanced Pancreatic Cancer · Treatment for Advanced Colorectal Cancer

#TreatmentforAdvancedColorectalCa#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleAmgenPhase 2

ABX-EGF (Panitumumab, Panitumumab (ABX-EGF))

Colorectal Cancer; Non-Small Cell Lung Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE

43 / 62 페이지

← 이전다음 →